Global Pets Anti-infective Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Pets Anti-infective Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pets Anti-infective Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pets Anti-infective Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pets Anti-infective Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pets Anti-infective Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pets Anti-infective Drugs include Zoetis, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva Santé Animale, Vetoquinol, Nanjing Jindun Animal and Wuhan Chopperlvya, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pets Anti-infective Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pets Anti-infective Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Pets Anti-infective Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pets Anti-infective Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pets Anti-infective Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pets Anti-infective Drugs sales, projected growth trends, production technology, application and end-user industry.


Pets Anti-infective Drugs Segment by Company

Zoetis
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva Santé Animale
Vetoquinol
Nanjing Jindun Animal
Wuhan Chopperlvya
Bimeda Animal Health
Ouro Fino Saude
Norbrook

Pets Anti-infective Drugs Segment by Administration Method
External Use
Internal Use
Injection

Pets Anti-infective Drugs Segment by Application

Dog
Cat
Others

Pets Anti-infective Drugs Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pets Anti-infective Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pets Anti-infective Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pets Anti-infective Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pets Anti-infective Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pets Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pets Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pets Anti-infective Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Pets Anti-infective Drugs Market Size, 2020 VS 2024 VS 2031
1.3 Global Pets Anti-infective Drugs Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pets Anti-infective Drugs Sales Estimates and Forecasts (2020-2031)
1.5 Global Pets Anti-infective Drugs Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pets Anti-infective Drugs Market Dynamics
2.1 Pets Anti-infective Drugs Industry Trends
2.2 Pets Anti-infective Drugs Industry Drivers
2.3 Pets Anti-infective Drugs Industry Opportunities and Challenges
2.4 Pets Anti-infective Drugs Industry Restraints
3 Pets Anti-infective Drugs Market by Manufacturers
3.1 Global Pets Anti-infective Drugs Revenue by Manufacturers (2020-2025)
3.2 Global Pets Anti-infective Drugs Sales by Manufacturers (2020-2025)
3.3 Global Pets Anti-infective Drugs Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pets Anti-infective Drugs Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pets Anti-infective Drugs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pets Anti-infective Drugs Manufacturers, Product Type & Application
3.7 Global Pets Anti-infective Drugs Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pets Anti-infective Drugs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pets Anti-infective Drugs Players Market Share by Revenue in 2024
3.8.3 2024 Pets Anti-infective Drugs Tier 1, Tier 2, and Tier 3
4 Pets Anti-infective Drugs Market by Type
4.1 Pets Anti-infective Drugs Type Introduction
4.1.1 External Use
4.1.2 Internal Use
4.1.3 Injection
4.2 Global Pets Anti-infective Drugs Sales by Type
4.2.1 Global Pets Anti-infective Drugs Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pets Anti-infective Drugs Sales by Type (2020-2031)
4.2.3 Global Pets Anti-infective Drugs Sales Market Share by Type (2020-2031)
4.3 Global Pets Anti-infective Drugs Revenue by Type
4.3.1 Global Pets Anti-infective Drugs Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pets Anti-infective Drugs Revenue by Type (2020-2031)
4.3.3 Global Pets Anti-infective Drugs Revenue Market Share by Type (2020-2031)
5 Pets Anti-infective Drugs Market by Application
5.1 Pets Anti-infective Drugs Application Introduction
5.1.1 Dog
5.1.2 Cat
5.1.3 Others
5.2 Global Pets Anti-infective Drugs Sales by Application
5.2.1 Global Pets Anti-infective Drugs Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pets Anti-infective Drugs Sales by Application (2020-2031)
5.2.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2020-2031)
5.3 Global Pets Anti-infective Drugs Revenue by Application
5.3.1 Global Pets Anti-infective Drugs Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pets Anti-infective Drugs Revenue by Application (2020-2031)
5.3.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2020-2031)
6 Global Pets Anti-infective Drugs Sales by Region
6.1 Global Pets Anti-infective Drugs Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pets Anti-infective Drugs Sales by Region (2020-2031)
6.2.1 Global Pets Anti-infective Drugs Sales by Region (2020-2025)
6.2.2 Global Pets Anti-infective Drugs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pets Anti-infective Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pets Anti-infective Drugs Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pets Anti-infective Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pets Anti-infective Drugs Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pets Anti-infective Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pets Anti-infective Drugs Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pets Anti-infective Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pets Anti-infective Drugs Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pets Anti-infective Drugs Revenue by Region
7.1 Global Pets Anti-infective Drugs Revenue by Region
7.1.1 Global Pets Anti-infective Drugs Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pets Anti-infective Drugs Revenue by Region (2020-2025)
7.1.3 Global Pets Anti-infective Drugs Revenue by Region (2026-2031)
7.1.4 Global Pets Anti-infective Drugs Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pets Anti-infective Drugs Revenue (2020-2031)
7.2.2 North America Pets Anti-infective Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pets Anti-infective Drugs Revenue (2020-2031)
7.3.2 Europe Pets Anti-infective Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pets Anti-infective Drugs Revenue (2020-2031)
7.4.2 Asia-Pacific Pets Anti-infective Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pets Anti-infective Drugs Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pets Anti-infective Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Zoetis
8.1.1 Zoetis Comapny Information
8.1.2 Zoetis Business Overview
8.1.3 Zoetis Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Zoetis Pets Anti-infective Drugs Product Portfolio
8.1.5 Zoetis Recent Developments
8.2 Merck
8.2.1 Merck Comapny Information
8.2.2 Merck Business Overview
8.2.3 Merck Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Merck Pets Anti-infective Drugs Product Portfolio
8.2.5 Merck Recent Developments
8.3 Elanco
8.3.1 Elanco Comapny Information
8.3.2 Elanco Business Overview
8.3.3 Elanco Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Elanco Pets Anti-infective Drugs Product Portfolio
8.3.5 Elanco Recent Developments
8.4 Virbac
8.4.1 Virbac Comapny Information
8.4.2 Virbac Business Overview
8.4.3 Virbac Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Virbac Pets Anti-infective Drugs Product Portfolio
8.4.5 Virbac Recent Developments
8.5 Dechra Veterinary Products
8.5.1 Dechra Veterinary Products Comapny Information
8.5.2 Dechra Veterinary Products Business Overview
8.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Portfolio
8.5.5 Dechra Veterinary Products Recent Developments
8.6 Ceva Santé Animale
8.6.1 Ceva Santé Animale Comapny Information
8.6.2 Ceva Santé Animale Business Overview
8.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Ceva Santé Animale Pets Anti-infective Drugs Product Portfolio
8.6.5 Ceva Santé Animale Recent Developments
8.7 Vetoquinol
8.7.1 Vetoquinol Comapny Information
8.7.2 Vetoquinol Business Overview
8.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Vetoquinol Pets Anti-infective Drugs Product Portfolio
8.7.5 Vetoquinol Recent Developments
8.8 Nanjing Jindun Animal
8.8.1 Nanjing Jindun Animal Comapny Information
8.8.2 Nanjing Jindun Animal Business Overview
8.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Portfolio
8.8.5 Nanjing Jindun Animal Recent Developments
8.9 Wuhan Chopperlvya
8.9.1 Wuhan Chopperlvya Comapny Information
8.9.2 Wuhan Chopperlvya Business Overview
8.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Portfolio
8.9.5 Wuhan Chopperlvya Recent Developments
8.10 Bimeda Animal Health
8.10.1 Bimeda Animal Health Comapny Information
8.10.2 Bimeda Animal Health Business Overview
8.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Portfolio
8.10.5 Bimeda Animal Health Recent Developments
8.11 Ouro Fino Saude
8.11.1 Ouro Fino Saude Comapny Information
8.11.2 Ouro Fino Saude Business Overview
8.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Portfolio
8.11.5 Ouro Fino Saude Recent Developments
8.12 Norbrook
8.12.1 Norbrook Comapny Information
8.12.2 Norbrook Business Overview
8.12.3 Norbrook Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Norbrook Pets Anti-infective Drugs Product Portfolio
8.12.5 Norbrook Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pets Anti-infective Drugs Value Chain Analysis
9.1.1 Pets Anti-infective Drugs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pets Anti-infective Drugs Production Mode & Process
9.2 Pets Anti-infective Drugs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pets Anti-infective Drugs Distributors
9.2.3 Pets Anti-infective Drugs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings